We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Filters

Equity Crowdfunding Pitches

Showing results
KindLink are a social network for donors and charities so donors are able to make a donation to their favourite charity and help them help other people. Donors are able to see the impact of the donations they are making by following the progress of the charity and updates for the project donated to. KindLink establishes a direct connection between donor and beneficiary to create a close and community-like feel.
days to go: Expired investment: £25,045
Koble claims that its data-driven Software as a Service (SaaS) tool helps accelerators and incubators streamline their selection process so they can focus on the most promising founders. The company's vision is to price early-stage startup risk and reward. It intends to move from a Software as a Service (SaaS) workflow tool to the startup-investor marketplace. Koble asserts that pre-seed and seed investors lack a quantitative approach in the early stage of recognising promising startups. Koble argues that its approach is different; it claims that its algorithms are built to mimic the decision processes (both analytical and intuitive) that humans go through when analysing a startup. The tool collects structured, well-tagged data that is not available in the public domain and power the first algorithms that can predict startup success. The company envisages three exit options, namely launching an IPO, avail buyout offers from big technology entities and avail buyout offers from financial buyers.
days to go: Expired investment: £525,500
Leaseum is a Business to Business (B2B) Software as a Service (SaaS) provider based in London that offers white label capital raising portals to its clients and targets alternative investment managers who deal with private equity, venture capital, real estate, hedge funds and private credit. The company claims that fundraising for alternative investments is time consuming, expensive and involves many compliance and regulatory aspects. It aims to change this by bringing together all the tools needed to raise capital such as an investor portal, a Customer Relationship Management (CRM) system, an email marketing module, e-signature facility, and investor onboarding compliances. Leaseum claims that it allows its clients to streamline their fundraising processes and convert more leads into investors via its portal. It will use 40% of the investment to strengthen its sales team, 40% to strengthen its IT team, and 20% for marketing.
days to go: Expired investment: £76,440
Lenderwize are a SEIS approved, UK based Crowdlending platform for Telcos. They seek to bridge the cash flow gap for telecom operators which sell to big operators and must pay their vendors upfront whilst waiting for their own clients to pay them. Lenderwize currently has a working platform with over £5,000,000 in requests from borrowers and over £9,000,000 from institutional investors.  
days to go: Expired investment: £78,076
Driving instructors struggle to acquire new pupils regularly themselves so they pay substantial amounts to franchises such as RED and AA for regular pupils. These franchises are expensive and inefficient but instructors have little choice. Our disruptive proposition offers all the benefits of a franchise in addition to new core features exclusive to Lessons Per Hour such as having a choice of pupils, exact travel distance and guaranteed payment from pupils before initial driving lessons.
days to go: Expired investment: £7,448
Driving instructors struggle to acquire new pupils regularly themselves so they pay substantial amounts to franchises such as RED and AA for regular pupils. These franchises are expensive and inefficient but instructors have little choice. Our disruptive proposition offers all the benefits of a franchise in addition to new core features exclusive to Lessons Per Hour such as having a choice of pupils, exact travel distance and guaranteed payment from pupils before initial driving lessons.
days to go: Expired investment: £7,448
MACACHA has designed natural protein shakes that have the nourishing power of plants, no artificial ingredients and have a positive impact on the environment, as well as looking beautiful on the kitchen counter!
days to go: Expired investment: £98,378
Mous is a fashion/tech brand that’s disrupting the $37billion phone accessories category. Mous has had huge exposure already for their latest ergonomic and slim iPhone 6 case that holds and retracts headphones, solving very real shopper problems. The trends of wireless earphones present a real opportunity for Mous in the future.
days to go: Expired investment: £41,580
Nourish'd aim to inspire a generation to live healthier, happier and more productive lives by offering nutritious food for breakfast, lunch, dinner and meetings. They know fuelling employees with delicious and low GI foods is key to boosting productivity and happiness in the workplace.
days to go: Expired investment: £123,180
Novai is a UK biotechnology company, developing and commercialising transformational technology in ophthalmology. The company's initial focus is on ophthalmic disorders such as glaucoma and AMD (Age-related Macular Degeneration). Novai argues that current clinical endpoints lack early disease biomarkers to objectively detect and measure cell health and response to treatment in the retina. Novai asserts that its proprietary biological marker, DARC (Detection of Apoptosis in Retinal Cells), combined with its bespoke and patented Artificial Intelligence (AI) aided algorithm, allows, for the first time in vivo, identification of cellular-level disease activity in the retina. Novai stresses that DARC can also predict disease progression, allowing for enrichment of clinical trial cohorts. The company anticipates an exit via licensing of its biomarker business to a Contract Research Organisation (CRO), an Initial Public Offering (IPO) following a successful phase 3 trial of the diagnostic platform, or trade sale to a strategic pharmaceutical company.
days to go: Expired investment: £1,314,967
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph